World’s biggest arms producers increased revenue last year to record level, report says

The 100 largest arms producers posted record arms and military services revenue of $679 billion in 2024, a 5.9% increase driven by demand related to the wars in Ukraine and Gaza and higher national defence spending. U.S. firms (39 companies) saw combined arms revenue rise 3.8% to $334 billion, European (ex-Russia) firms rose 13% to $151 billion, Russian firms grew 23% to $31.2 billion on domestic demand, while Asia and Oceania fell 1.2% to $130 billion led by a 10% drop among Chinese companies. The sector is expanding production capacity but faces headwinds including US program delays and overruns, Chinese procurement corruption and contract cancellations, and potential supply-chain constraints for critical minerals.

Analysis

Market structure: The SIPRI data imply concentration: prime US/EU primes (Lockheed LMT, Northrop NOC, General Dynamics GD) capture most incremental $≈38bn revenue growth (5.9% on $679bn) as governments prioritize proven platforms. Pricing power rises where capacity is constrained — expect 5–15% margins expansion for prime contractors that can pass through higher input costs and secure multiyear contracts; smaller tier‑2 suppliers face margin compression and order volatility. Cross-asset: higher defense capex supports cyclicals (steel, copper, specialty alloys) and is modestly hawkish for long-term bond supply; USD likely to strengthen on sustained US defense spending and safe‑haven flows.

Risk assessment: Key tail risks are regulatory (stricter export controls or sanctions that cut key export markets), major program failures (another F‑35‑style overrun), or sudden budget cuts if macro deteriorates; probability moderate but impact high (earnings shock >20%). Time horizons: immediate (days) — earnings/contract announcements can spike vols; short (3–12 months) — capacity buildouts and procurement decisions materialize; long (1–3 years) — supply‑chain reconfiguration and critical‑minerals constraints determine sustainable margins. Hidden dependencies include critical‑minerals exposure (rare earths, titanium, copper) and single‑source suppliers in Asia; watch Chinese export policy and corruption probes that can re‑route orders.

Trade implications: Favor large-cap primes with backlog visibility and balance‑sheet strength. Tactical plays: (a) selective longs in LMT/NOC for defensive, cash‑generative exposure to multi‑year US/EU budgets; (b) buy commodity/RE players (MP, REMX) to benefit from upstream squeeze if sourcing becomes constrained; (c) avoid or hedge China‑exposed defense suppliers and small-cap subcontractors where cancellations rose ~10% in 2024. Use options to buy convexity around 3–9 month procurement events and budget votes.

Contrarian angles: The market underestimates supply‑side bottlenecks — if critical‑minerals export curbs tighten, upstreams outperform primes (where production can’t ramp fast). Conversely, consensus may be overplaying secular upside in names already priced for perfection; primes trade at premium multiples and are vulnerable to a single large program delay. Historical parallels: 2008–12 defense buildouts showed outsized returns in metal and ordnance suppliers before prime contractors. Unintended consequence: aggressive EU/US reshoring can amplify unit costs and delay deliveries, creating short‑term dislocations for contractors and opportunities for specialized suppliers.

Key Decisions for Investors

• Establish a 1.5–2.5% portfolio long in Lockheed Martin (LMT) and a 1.5–2.5% long in Northrop Grumman (NOC) over the next 2–6 weeks; target 12–20% upside over 6–12 months on backlog conversion and EU/US budget renewals, set stop-loss at 8% and trim if either issues >5% downward guidance to FY26 revenue.
• Buy 3–6 month call spreads on LMT and NOC (buy 1–2% OTM call, sell 6–8% OTM call) sized to equal a 0.5–1% delta exposure each to capture order/contract announcements while capping premium; roll or exit on materiality events (DoD budget passage, major EU procurement) within 90 days.
• Allocate 1–2% to upstream commodities/rare‑earth exposure (e.g., MP Materials MP or REMX ETF) as a hedge for supply‑chain driven price appreciation; reduce if rare‑earth export curbs are eased or if prices rally >30% from entry.
• Avoid/add short exposure (or hedge via single‑stock puts) to small-cap/subcontractor defense names and China‑exposed suppliers for 3–12 months; if Chinese defense revenues fall another 5–10% or corruption probes expand, increase hedges until order transparency returns.
• Monitor three catalysts on a 30–90 day cadence before scaling: (1) US DoD budget vote (threshold: <$2bn deviation from consensus orders), (2) EU national procurement announcements (track €bn scale projects), and (3) Chinese export/control policy updates — if any produce >5% negative guidance to backlog, reduce prime exposure by 50% within 5 trading days.